Veracyte Inc. | Ownership
Companies that own Veracyte Inc.
ARK Investment Management LLC
3,760,659
9.53%
949,365
1.56%
06/30/2018
Acuta Capital Partners LLC
2,660,210
6.75%
-657,790
5.87%
06/30/2018
Cannell Capital LLC
2,412,344
6.12%
353,111
6.77%
06/30/2018
Eventide Asset Management LLC
2,133,500
5.41%
0
1.03%
06/30/2018
BlackRock Fund Advisors
1,728,888
4.38%
221,597
0%
06/30/2018
The Vanguard Group, Inc.
981,677
2.49%
19,632
0%
06/30/2018
First Light Asset Management LLC
881,983
2.24%
32,417
1.48%
06/30/2018
Millennium Management LLC
861,836
2.19%
136,096
0.01%
06/30/2018
Renaissance Technologies LLC
505,400
1.28%
-7,400
0.01%
06/30/2018
Bridgeway Capital Management, Inc.
356,800
0.91%
0
0.04%
06/30/2018
| Address |
6000 Shoreline Court
South San Francisco California 94080
United States
|
|
Employees
|
- |
| Website |
http://www.veracyte.com |
| Updated |
07/08/2019 |
| Veracyte, Inc. engages in the research, development, and commercialization of diagnostic products. Its portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. |
